EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

From vial to prefilled delivery devices in autoimmune diseases: Exploring the formulation and technological pharmaceutical challenges

Amélia C F Vieira, Gustavo Costa, Inês Silva, Sofia Maurício, Daniela Martins-Pimenta, Hugo Almeida, Victoria Bell, Francisco Veiga, Ana Cláudia Paiva-Santos

European Journal of Pharmaceutics and Biopharmaceutics · 2026

DOI: 10.1016/j.ejpb.2026.115030 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2026. Verfasst von Amélia C F Vieira und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Coimbra, Portugal; LAQV/REQUIMTE, D…. Hauptthemen laut MEDLINE: Autoimmune Diseases, Drug Delivery Systems. Die Arbeit nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The use of medicines in the daily clinical practice and meeting the desired effectiveness is many times dependent upon patient experience and compliance with the therapy. This is particularly relevant in chronic diseases, such as the case of autoimmune diseases. The management of autoimmune diseases often involves the regular administration of biologic therapies, which require precise dosing and consistent adherence to treatment regimens. Prefilled syringes, prefilled pens, and auto-injectors have emerged as pivotal tools in this therapeutic landscape, offering significant benefits in terms of convenience, safety, and accuracy. Despite the R&D efforts involved in the repurposing of the pharmaceutical form from a vial to a ready-to-use prefilled syringe, the time saved for both doctor and patient, and the convenience to the patient are intangible values. This review provides a comprehensive overview of the use of drug prefilled delivery devices in the treatment of autoimmune diseases. A special focus is given to the formulation differences when comparing vials with prefilled delivery devices, addressing the modifications in terms of strength, primary packaging, shelf life, and excipients. It delves into the technological advancements that have led to the development of these devices, describing the composition and function of each component on the currently marketed injectable drug delivery devices for autoimmune diseases. Through a review of current research and clinical practices, this study highlights the critical role these devices play in enhancing the effectiveness of autoimmune disease management, ultimately leading to better patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune DiseasesDrug Delivery SystemsHumansSyringesDrug PackagingDrug CompoundingChemistry, PharmaceuticalExcipientsTechnology, Pharmaceutical

Stichwörter der Autor:innen

Autoimmune diseaseFormulationInjectablePatient adherencePrefilled delivery devicePrefilled penPrefilled syringe

Substanzen

Excipients

Autor:innen und Institutionen

  • Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Coimbra, Portugal; LAQV/REQUIMTE, Department of Pharmaceutical Technology, Faculty of Pharmacy of the Uni…
  • Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Coimbra, Portugal.
  • Department of Pharmaceutical Technology, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Coimbra, Portugal; Independent Consultant, Lisbon, Portugal.
  • Social Pharmacy and Public Health Laboratory, Faculty of Pharmacy of the University of Coimbra, University of Coimbra, Coimbra, Portugal.

Zitieren

APA

Vieira, A. C. F., Costa, G., Silva, I., Maurício, S., Martins-Pimenta, D., Almeida, H., Bell, V., Veiga, F., & Paiva-Santos, A. C. (2026). From vial to prefilled delivery devices in autoimmune diseases: Exploring the formulation and technological pharmaceutical challenges. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2026.115030

Vancouver

Vieira ACF, Costa G, Silva I, Maurício S, Martins-Pimenta D, Almeida H, et al. From vial to prefilled delivery devices in autoimmune diseases: Exploring the formulation and technological pharmaceutical challenges. European Journal of Pharmaceutics and Biopharmaceutics. 2026. doi:10.1016/j.ejpb.2026.115030

BibTeX
@article{Vieira2026,
  author = {Vieira, Amélia C F and Costa, Gustavo and Silva, Inês and Maurício, Sofia and Martins-Pimenta, Daniela and Almeida, Hugo and Bell, Victoria and Veiga, Francisco and Paiva-Santos, Ana Cláudia},
  title = {From vial to prefilled delivery devices in autoimmune diseases: Exploring the formulation and technological pharmaceutical challenges},
  journal = {European Journal of Pharmaceutics and Biopharmaceutics},
  year = {2026},
  doi = {10.1016/j.ejpb.2026.115030}
}
Kostenlos starten →